About Adagene
Adagene is a company based in Suzhou (China) founded in 2012 by Peter Luo.. Adagene has raised $155 million across 5 funding rounds from investors including WuXi AppTec, General Atlantic and Sanofi. The company has 138 employees as of December 31, 2024. Adagene operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Suzhou, China
- Employees 138 as on 31 Dec, 2024
- Founders Peter Luo
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Adagene, Inc. Sponsored Adr
-
Annual Revenue
$103.2 K-99.43as on Dec 31, 2024
-
Net Profit
$-33.42 M-76.41as on Dec 31, 2024
-
EBITDA
$-35.03 M-34.69as on Dec 31, 2024
-
Total Equity Funding
$155 M (USD)
in 5 rounds
-
Latest Funding Round
$25 M (USD), Post-IPO
Jul 01, 2025
-
Investors
WuXi AppTec
& 12 more
-
Employee Count
138
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Adagene
Adagene is a publicly listed company on the NASDAQ with ticker symbol ADAG in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Adagene
Adagene has successfully raised a total of $155M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $25 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $25.0M
-
First Round
First Round
(08 Dec 2014)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2025 | Amount | Post-IPO - Adagene | Valuation |
investors |
|
| Jan, 2020 | Amount | Series D - Adagene | Valuation | General Atlantic | |
| Mar, 2018 | Amount | Series C - Adagene | Valuation | Sequoia Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Adagene
Adagene has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include WuXi AppTec, General Atlantic and Sanofi. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund focused on global markets
|
Founded Year | Domain | Location | |
|
Venture capital investment and global platform support for startups.
|
Founded Year | Domain | Location | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Adagene
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Adagene
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Adagene Comparisons
Competitors of Adagene
Adagene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Adagene
Frequently Asked Questions about Adagene
When was Adagene founded?
Adagene was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Where is Adagene located?
Adagene is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
Who is the current CEO of Adagene?
Peter Luo is the current CEO of Adagene. They have also founded this company.
Is Adagene a funded company?
Adagene is a funded company, having raised a total of $155M across 5 funding rounds to date. The company's 1st funding round was a Series C of $50M, raised on Dec 08, 2014.
How many employees does Adagene have?
As of Dec 31, 2024, the latest employee count at Adagene is 138.
What is the annual revenue of Adagene?
Annual revenue of Adagene is $103.2K as on Dec 31, 2024.
What does Adagene do?
Adagene was founded in 2012 in Suzhou, China, and operates in the biotechnology sector focused on cancer immunotherapy. Antibodies are developed, including ADG106 as an agonist for CD137 in metastatic solid tumors, ADG126 targeting CTLA4 for cancer therapy, and ADG116 targeting a CTLA4 epitope in metastatic solid tumors and relapsedrefractory non-Hodgkins lymphoma. Operations center on advancing these therapies for oncology applications.
Who are the top competitors of Adagene?
Adagene's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Is Adagene publicly traded?
Yes, Adagene is publicly traded on NASDAQ under the ticker symbol ADAG.
Who are Adagene's investors?
Adagene has 13 investors. Key investors include WuXi AppTec, General Atlantic, Sanofi, Fidelity International, and Eight Roads Ventures.
What is Adagene's ticker symbol?
The ticker symbol of Adagene is ADAG on NASDAQ.